Cargando…

Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure

Endothelial cells are, by number, one of the most abundant cell types in the heart and active players in cardiac physiology and pathology. Coronary angiogenesis plays a vital role in maintaining cardiac vascularization and perfusion during physiological and pathological hypertrophy. On the other han...

Descripción completa

Detalles Bibliográficos
Autores principales: Gogiraju, Rajinikanth, Bochenek, Magdalena L., Schäfer, Katrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415587/
https://www.ncbi.nlm.nih.gov/pubmed/30895179
http://dx.doi.org/10.3389/fcvm.2019.00020
_version_ 1783403215174238208
author Gogiraju, Rajinikanth
Bochenek, Magdalena L.
Schäfer, Katrin
author_facet Gogiraju, Rajinikanth
Bochenek, Magdalena L.
Schäfer, Katrin
author_sort Gogiraju, Rajinikanth
collection PubMed
description Endothelial cells are, by number, one of the most abundant cell types in the heart and active players in cardiac physiology and pathology. Coronary angiogenesis plays a vital role in maintaining cardiac vascularization and perfusion during physiological and pathological hypertrophy. On the other hand, a reduction in cardiac capillary density with subsequent tissue hypoxia, cell death and interstitial fibrosis contributes to the development of contractile dysfunction and heart failure, as suggested by clinical as well as experimental evidence. Although the molecular causes underlying the inadequate (with respect to the increased oxygen and energy demands of the hypertrophied cardiomyocyte) cardiac vascularization developing during pathological hypertrophy are incompletely understood. Research efforts over the past years have discovered interesting mediators and potential candidates involved in this process. In this review article, we will focus on the vascular changes occurring during cardiac hypertrophy and the transition toward heart failure both in human disease and preclinical models. We will summarize recent findings in transgenic mice and experimental models of cardiac hypertrophy on factors expressed and released from cardiomyocytes, pericytes and inflammatory cells involved in the paracrine (dys)regulation of cardiac angiogenesis. Moreover, we will discuss major signaling events of critical angiogenic ligands in endothelial cells and their possible disturbance by hypoxia or oxidative stress. In this regard, we will particularly highlight findings on negative regulators of angiogenesis, including protein tyrosine phosphatase-1B and tumor suppressor p53, and how they link signaling involved in cell growth and metabolic control to cardiac angiogenesis. Besides endothelial cell death, phenotypic conversion and acquisition of myofibroblast-like characteristics may also contribute to the development of cardiac fibrosis, the structural correlate of cardiac dysfunction. Factors secreted by (dysfunctional) endothelial cells and their effects on cardiomyocytes including hypertrophy, contractility and fibrosis, close the vicious circle of reciprocal cell-cell interactions within the heart during pathological hypertrophy remodeling.
format Online
Article
Text
id pubmed-6415587
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-64155872019-03-20 Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure Gogiraju, Rajinikanth Bochenek, Magdalena L. Schäfer, Katrin Front Cardiovasc Med Cardiovascular Medicine Endothelial cells are, by number, one of the most abundant cell types in the heart and active players in cardiac physiology and pathology. Coronary angiogenesis plays a vital role in maintaining cardiac vascularization and perfusion during physiological and pathological hypertrophy. On the other hand, a reduction in cardiac capillary density with subsequent tissue hypoxia, cell death and interstitial fibrosis contributes to the development of contractile dysfunction and heart failure, as suggested by clinical as well as experimental evidence. Although the molecular causes underlying the inadequate (with respect to the increased oxygen and energy demands of the hypertrophied cardiomyocyte) cardiac vascularization developing during pathological hypertrophy are incompletely understood. Research efforts over the past years have discovered interesting mediators and potential candidates involved in this process. In this review article, we will focus on the vascular changes occurring during cardiac hypertrophy and the transition toward heart failure both in human disease and preclinical models. We will summarize recent findings in transgenic mice and experimental models of cardiac hypertrophy on factors expressed and released from cardiomyocytes, pericytes and inflammatory cells involved in the paracrine (dys)regulation of cardiac angiogenesis. Moreover, we will discuss major signaling events of critical angiogenic ligands in endothelial cells and their possible disturbance by hypoxia or oxidative stress. In this regard, we will particularly highlight findings on negative regulators of angiogenesis, including protein tyrosine phosphatase-1B and tumor suppressor p53, and how they link signaling involved in cell growth and metabolic control to cardiac angiogenesis. Besides endothelial cell death, phenotypic conversion and acquisition of myofibroblast-like characteristics may also contribute to the development of cardiac fibrosis, the structural correlate of cardiac dysfunction. Factors secreted by (dysfunctional) endothelial cells and their effects on cardiomyocytes including hypertrophy, contractility and fibrosis, close the vicious circle of reciprocal cell-cell interactions within the heart during pathological hypertrophy remodeling. Frontiers Media S.A. 2019-03-06 /pmc/articles/PMC6415587/ /pubmed/30895179 http://dx.doi.org/10.3389/fcvm.2019.00020 Text en Copyright © 2019 Gogiraju, Bochenek and Schäfer. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Gogiraju, Rajinikanth
Bochenek, Magdalena L.
Schäfer, Katrin
Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure
title Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure
title_full Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure
title_fullStr Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure
title_full_unstemmed Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure
title_short Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure
title_sort angiogenic endothelial cell signaling in cardiac hypertrophy and heart failure
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415587/
https://www.ncbi.nlm.nih.gov/pubmed/30895179
http://dx.doi.org/10.3389/fcvm.2019.00020
work_keys_str_mv AT gogirajurajinikanth angiogenicendothelialcellsignalingincardiachypertrophyandheartfailure
AT bochenekmagdalenal angiogenicendothelialcellsignalingincardiachypertrophyandheartfailure
AT schaferkatrin angiogenicendothelialcellsignalingincardiachypertrophyandheartfailure